NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19)

NCT04442230 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

48

Enrollment

INDUSTRY

Sponsor class

Stopped Enrollment

Conditions

Coronavirus Infection

Interventions

BIOLOGICAL: NasoVAX
OTHER: Placebo

Sponsor

Altimmune, Inc.